Headlands Research Acquires Six Clinical Research Sites As It Seeks to Transform the Clinical Trial Process
KKR & Co. Inc. (KKR)
Last kkr & co. inc. earnings: 1/31 06:50 am
Check Earnings Report
US:NYSE Investor Relations:
ir.kkr.com
Company Research
Source: GlobeNewswire
SAN FRANCISCO, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Headlands Research, a KKR-backed next-generation site organization seeking to profoundly impact the clinical trial landscape, today announced that it has acquired six clinical research centers across the U.S. and Canada, establishing a strong foundation to fulfill its mission to make high-quality therapeutics available to patients in an expedited manner. The six acquired research centers span three organizations: Centex Studies, Clinical Research Atlanta, and Okanagan Clinical Trials. Headlands Research aims to disrupt the status quo by leveraging patient-centric best practices to significantly increase the number of people who take part in trials and exceed industry standards with the highest quality data. The acquisition of these six highly regarded and well-established research centers with long-standing research expertise gives the organization a substantial footprint in the site organization landscape. “The acquisitions of
Show less
Read more
Impact Snapshot
Event Time:
KKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KKR alerts
High impacting KKR & Co. Inc. news events
Weekly update
A roundup of the hottest topics
KKR
News
- KKR to Acquire $1.64 Billion Student Housing Portfolio from BREITBusiness Wire
- KKR & Co. Inc. (NYSE: KKR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Glucose Monitoring Device Market Value to Reach a Staggering US$ 44.6 Billion by 2034 Amid High Diabetes Prevalence Globally | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Agital Gains Competitive Edge with Appointment of Daniel Street to Board of Directors [Yahoo! Finance]Yahoo! Finance
- KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma [Yahoo! Finance]Yahoo! Finance
KKR
Earnings
- 2/7/24 - Beat
KKR
Sec Filings
- 4/10/24 - Form 8-K
- 4/10/24 - Form 8-K
- 3/27/24 - Form 8-K
- KKR's page on the SEC website